Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction
- Conditions
- Proximal Tubule DysfunctionSARS-CoV2 Infection
- Registration Number
- NCT04937712
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
The primary goal is to detect Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) urine viral particles in patients in intensive care units, hospitalized for coronavirus Coronavirus Disease-19 (COVID-19) infection, and correlate the presence of the virus in the urine with proximal tubular dysfunction (defined by the association of at least 2 abnormalities: tubular proteinuria, renal phosphate leak, uricosuria, normoglycemic glycosuria, amino aciduria)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 34
- Person and / or trustworthy person who has received complete information on the organization of the research and who has not opposed their participation and the use of their data
- Hospitalized for ≥ 48 hours and ≤ 10 days
- SARS-CoV-2 positive nasopharyngeal sample
- Severity criteria: Lung involvement described as compatible with SARS-CoV-2 on radiography or scanner and partial pressure of oxygne (PaO2) / Fraction of inspired oxygen (FiO2) ≤ 300 mmHg and / or respiratory rate (RR) ≥ 30 / min
- Known chronic kidney disease, or initial Glomerular Filtration Rate (GFR) <60 ml / min / 1.73m2 or Renal Transplant
- Known proteinuria
- Known proximal tubulopathy
- Treatment with Forxiga
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SARS-CoV 2 viruria and its correlation with proximal tubule dysfunction During the first 10 days of hospitalization Is the detection of viral particles in urine associated with proximal tubule dysfunction, defined by two or more of the following : proteinuria, phosphate leak, aminoaciduria, hyperuricuria, and/or glycosuria
- Secondary Outcome Measures
Name Time Method Capacity of infection of urine viral particles During the first 10 days of hospitalization Study of the capacity for cell infection in vitro by viral particles detected in urine.
Sequencing viral particles to identify possible compartmentalization of the virus During the first 10 days of hospitalization Study by sequencing of the compartmentalization of urinary and nasopharyngeal variants of SARS-CoV-2 in patients with positive urine for SARS-CoV-2.
Trial Locations
- Locations (1)
Chru Brabois
🇫🇷Nancy, France